Evidence for single-dose protection by the bivalent HPV vaccine—Review of the Costa Rica HPV vaccine trial and future research studies - Kreimer, Aimée R.; Herrero, Rolando; Sampson, Joshua N.; Porras, Carolina; Lowy, Douglas R.; Schiller, John T.; Schiffman, Mark; Rodriguez, Ana Cecilia; Chanock, Stephen; Jimenez, Silvia; Schussler, John; Gail, Mitchell H.; et al. (Vaccine, 2018)
Keywords: Adolescent; Adult; Allergy and Immunology; antibodies; Antibodies, Viral - immunology; Antibody response; Cervical cancer; Clinical trials; Clinical Trials as Topic; Costa Rica; Costa Rica - epidemiology; Deoxyribonucleic acid; DNA; Durability; experimental design; Female; HPV; HPV-driven cancers; Human papillomavirus; Human papillomavirus 16 - immunology; Human papillomavirus 18 - immunology; Humans; Immunization Schedule; Laboratories; Mass Vaccination; Medical screening; Papillomavirus Infections - epidemiology; Papillomavirus Infections - prevention & control; Papillomavirus Infections - therapy; Papillomavirus Vaccines - administration & dosage; Papillomavirus Vaccines - therapeutic use; Prevention; Reduced dose; Serum - immunology; Studies; Time Factors; Uterine Cervical Neoplasms - epidemiology; Uterine Cervical Neoplasms - prevention & control; Uterine Cervical Neoplasms - therapy; Vaccination; Vaccine; Vaccines; women; Womens health; United States--US; Costa Rica; Prevention; Human papillomavirus; HPV-driven cancers; Reduced dose; Vaccine; Cervical cancer; HPV